Literature DB >> 15472292

Serotypes and sequence types of pneumococci causing invasive disease in Scotland prior to the introduction of pneumococcal conjugate polysaccharide vaccines.

S C Clarke1, K J Scott, S M McChlery.   

Abstract

Pneumococcal conjugate polysaccharide (Pnc) vaccines are now available, and the need for an improved understanding of circulating pneumococcal serotypes and sequence types (STs) is recognized. Three hundred sixty-eight pneumococci isolated in cases of invasive disease in Scotland in the first 6 months of 2003 were analyzed. The isolates belonged to 30 serotypes, and there was a strong correlation between serotype and ST, although only nine serotypes consisted of a single ST. The following serotypes coexisted with the following numbers of STs: serotype 14, 10 STs, serotype 8, 8 STs; serotype 4, 6 STs; serotype 22F, 8 STs; serotype 9V, 7 STs; serotype 23F, 6 STs; serotype 6B, 6 STs; serotype 1, 3 STs; serotype 3, 3 STs; and serotype 7F, 3 STs. Our data also showed a strong association between ST and serotype, although 19 STs contained multiple serotypes. Of the 10 most common STs, 6 coexisted with a single serotype each. Vaccine coverage in all age groups was 94.9% for the 23-valent polysaccharide vaccine and 50.7, 55.4, and 64.1% for the 7-, 9-, and 11-valent Pnc vaccines, respectively. For those under the age of 2 years, 79% coverage would be provided by the 7-, 9-, and 11-valent Pnc vaccines.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15472292      PMCID: PMC522285          DOI: 10.1128/JCM.42.10.4449-4452.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  24 in total

1.  Prevention of pneumococcal disease by vaccination: does serotype replacement matter?

Authors:  B G Spratt; B M Greenwood
Journal:  Lancet       Date:  2000-10-07       Impact factor: 79.321

2.  Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers.

Authors:  Ron Dagan; Noga Givon-Lavi; Orly Zamir; Merav Sikuler-Cohen; Lior Guy; Jacob Janco; Pablo Yagupsky; Drora Fraser
Journal:  J Infect Dis       Date:  2002-03-04       Impact factor: 5.226

3.  Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers.

Authors:  H R Shinefield; S Black; P Ray; I Chang; N Lewis; B Fireman; J Hackell; P R Paradiso; G Siber; R Kohberger; D V Madore; F J Malinowski; A Kimura; C Le; I Landaw; J Aguilar; J Hansen
Journal:  Pediatr Infect Dis J       Date:  1999-09       Impact factor: 2.129

4.  Tolerability and immunogenicity of an 11-valent pneumococcal conjugate vaccine in adults.

Authors:  T Wuorimaa; H Käyhty; O Leroy; J Eskola
Journal:  Vaccine       Date:  2001-02-28       Impact factor: 3.641

Review 5.  Pneumococcal disease in childhood.

Authors:  P V Mohan; P T Heath
Journal:  Hosp Med       Date:  2001-07

6.  Serotypes/groups distribution and antimicrobial resistance of invasive pneumococcal isolates: implications for vaccine strategies.

Authors:  M H Kyaw; S Clarke; G F Edwards; I G Jones; H Campbell
Journal:  Epidemiol Infect       Date:  2000-12       Impact factor: 2.451

Review 7.  The pneumococcus: carriage, disease and conjugate vaccines.

Authors:  Steven Obaro; Richard Adegbola
Journal:  J Med Microbiol       Date:  2002-02       Impact factor: 2.472

8.  Molecular typing of bacteria directly from cerebrospinal fluid.

Authors:  M C Enright; K Knox; D Griffiths; D W Crook; B G Spratt
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-08       Impact factor: 3.267

9.  Efficacy of a pneumococcal conjugate vaccine against acute otitis media.

Authors:  J Eskola; T Kilpi; A Palmu; J Jokinen; J Haapakoski; E Herva; A Takala; H Käyhty; P Karma; R Kohberger; G Siber; P H Mäkelä
Journal:  N Engl J Med       Date:  2001-02-08       Impact factor: 91.245

Review 10.  Efficacy of pneumococcal conjugate vaccines and their effect on carriage and antimicrobial resistance.

Authors:  K P Klugman
Journal:  Lancet Infect Dis       Date:  2001-09       Impact factor: 25.071

View more
  9 in total

1.  Clonal analysis of invasive pneumococcal isolates in Scotland and coverage of serotypes by the licensed conjugate polysaccharide pneumococcal vaccine: possible implications for UK vaccine policy.

Authors:  S M McChlery; K J Scott; S C Clarke
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-04       Impact factor: 3.267

2.  Multilocus sequence types, serotypes, and variants of the surface antigen PspA in Streptococcus pneumoniae isolates from meningitis patients in Poland.

Authors:  Ewa Sadowy; Anna Skoczyñska; Janusz Fiett; Marek Gniadkowski; Waleria Hryniewicz
Journal:  Clin Vaccine Immunol       Date:  2006-01

3.  Potential impact of conjugate vaccine on the incidence of invasive pneumococcal disease among children in Scotland.

Authors:  Stuart C Clarke; Johanna M Jefferies; Andrew J Smith; Jim McMenamin; Timothy J Mitchell; Giles F S Edwards
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

4.  An unusual pneumococcal sequence type is the predominant cause of serotype 3 invasive disease in South Africa.

Authors:  Kedibone M Mothibeli; Mignon du Plessis; Anne von Gottberg; Linda de Gouveia; Peter Adrian; Shabir A Madhi; Keith P Klugman
Journal:  J Clin Microbiol       Date:  2009-11-04       Impact factor: 5.948

5.  A new variant of the capsule 3 cluster occurs in Streptococcus pneumoniae from deceased wild chimpanzees.

Authors:  Dalia Denapaite; Regine Hakenbeck
Journal:  PLoS One       Date:  2011-09-28       Impact factor: 3.240

Review 6.  A systematic review of the burden of vaccine preventable pneumococcal disease in UK adults.

Authors:  James D Chalmers; James Campling; Alison Dicker; Mark Woodhead; Harish Madhava
Journal:  BMC Pulm Med       Date:  2016-05-11       Impact factor: 3.317

7.  Global emergence and population dynamics of divergent serotype 3 CC180 pneumococci.

Authors:  Taj Azarian; Patrick K Mitchell; Maria Georgieva; Claudette M Thompson; Amel Ghouila; Andrew J Pollard; Anne von Gottberg; Mignon du Plessis; Martin Antonio; Brenda A Kwambana-Adams; Stuart C Clarke; Dean Everett; Jennifer Cornick; Ewa Sadowy; Waleria Hryniewicz; Anna Skoczynska; Jennifer C Moïsi; Lesley McGee; Bernard Beall; Benjamin J Metcalf; Robert F Breiman; P L Ho; Raymond Reid; Katherine L O'Brien; Rebecca A Gladstone; Stephen D Bentley; William P Hanage
Journal:  PLoS Pathog       Date:  2018-11-26       Impact factor: 6.823

8.  Molecular characterization and epidemiology of Streptococcus pneumoniae serotype 8 in Denmark.

Authors:  Camilla Bülow Hansen; Kurt Fuursted; Palle Valentiner-Branth; Tine Dalby; Charlotte Sværke Jørgensen; H-C Slotved
Journal:  BMC Infect Dis       Date:  2021-05-05       Impact factor: 3.090

9.  Molecular epidemiology of serotype 19A Streptococcus pneumoniae among invasive isolates from Alaska, 1986-2010.

Authors:  Karen Rudolph; M G Bruce; L Bulkow; T Zulz; A Reasonover; M Harker-Jones; D Hurlburt; T W Hennessy
Journal:  Int J Circumpolar Health       Date:  2013-08-05       Impact factor: 1.228

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.